Vasospastic Angina

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2025-04-16
FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.